Psyence Biomedical (PBM) EPS (Basic) (2023 - 2025)

Psyence Biomedical (PBM) recorded quarterly EPS (Basic) of -$0.0 in Q3 2025, down 100.01% quarter-over-quarter from $0.28 in Q3 2024, and down 100.01% on a YoY basis from $0.28 in Q3 2024.

Psyence Biomedical (PBM) EPS (Basic) (2023 - 2025) Analysis & Trends

Psyence Biomedical's EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.0 for Q3 2025.

  • In Q3 2025, EPS (Basic) fell 100.01% year-over-year to -$0.0; the TTM figure through Sep 2025 stood at $0.28 (changed N/A YoY), while the FY2025 annual figure was $5.24, up 100.11% from the prior year.
  • EPS (Basic) was -$0.0 for Q3 2025 at Psyence Biomedical, down from $0.28 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.28 in Q3 2024 to a low of -$0.07 in Q1 2023.
  • Historically, EPS (Basic) has averaged $0.07 across 3 years, with a median of -$0.0 in 2025.
  • Biggest YoY gain for EPS (Basic) was 100.01% in 2025; the steepest drop was 100.01% in 2025.
  • A 3-year view of EPS (Basic) shows it stood at -$0.07 in 2023, then jumped by 534.13% to $0.28 in 2024, then sank by 100.01% to -$0.0 in 2025.
  • The last three EPS (Basic) figures came in at -$0.0 (Q3 2025), $0.28 (Q3 2024), and -$0.07 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -0.68
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 3.06
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.00
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 0.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 0.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 0.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 4.06
9 Abivax 94.26 Bn 94.26 Bn - -0.06
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 6.99

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Sep 30, 2024 0.28
Mar 31, 2023 -0.07